<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37565734</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>SHFL inhibits enterovirus A71 infection by triggering degradation of viral 3D<sup>pol</sup> protein via the ubiquitin-proteasome pathway.</ArticleTitle><Pagination><StartPage>e29030</StartPage><MedlinePgn>e29030</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29030</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) is a highly contagious virus that poses a major threat to global health, representing the primary etiological agent for hand-foot and mouth disease (HFMD) and neurological complications. It has been established that interferon signaling is critical to establishing a robust antiviral state in host cells, mainly mediated through the antiviral effects of numerous interferon-stimulated genes (ISGs). The host restriction factor SHFL is a novel ISG with broad antiviral activity against various viruses through diverse underlying molecular mechanisms. Although SHFL is widely acknowledged for its broad-spectrum antiviral activity, it remains elusive whether SHFL inhibits EV-A71. In this work, we validated that EV-A71 triggers the upregulation of SHFL both in cell lines and in a mouse model. Knockdown and overexpression of SHFL in EVA71-infected cells suggested that this factor could markedly suppress EV-A71 replication. Our findings further revealed an intriguing mechanism of SHFL that it could interact with the nonstructural proteins 3D<sup>pol</sup> of EV-A71 and promoted the degradation of 3D<sup>pol</sup> through the ubiquitin-proteasome pathway. Furthermore, the zinc-finger domain and the 36 amino acids (164-199) of SHFL were crucial to the interaction between SHFL and EV-A71 3D<sup>pol</sup> . Overall, these findings broadened our understanding of the pivotal roles of SHFL in the interaction between the host and EV-A71.</AbstractText><CopyrightInformation>© 2023 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Chahui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Zhongshan School of Medicine, Research Center for Clinical Laboratory Standard, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Changsha Medical University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Xingliang</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-4440-0287</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Zhongshan School of Medicine, Research Center for Clinical Laboratory Standard, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Yongyao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Zhongshan School of Medicine, Research Center for Clinical Laboratory Standard, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Xinhuai</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shunde Hospital, Medical Research Center, Southern Medical University (The First People's Hospital of Shunde), Foshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Delin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Zhongshan School of Medicine, Research Center for Clinical Laboratory Standard, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Linyue</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Zhongshan School of Medicine, Research Center for Clinical Laboratory Standard, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinling</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Zhongshan School of Medicine, Research Center for Clinical Laboratory Standard, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Ruoxi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory Medicine, University-Town Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Kaiyuan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Zhongshan School of Medicine, Research Center for Clinical Laboratory Standard, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zhenjian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Guohong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Mingxing</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Central Laboratory, The Third People's Hospital of Zhuhai, Zhuhai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Zhongshan School of Medicine, Research Center for Clinical Laboratory Standard, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central Laboratory, The Third People's Hospital of Zhuhai, Zhuhai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015684">Gene Products, pol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014452">Ubiquitins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015684" MajorTopicYN="N">Gene Products, pol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014452" MajorTopicYN="N">Ubiquitins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SHFL</Keyword><Keyword MajorTopicYN="N">enterovirus A71</Keyword><Keyword MajorTopicYN="N">hand-foot-mouth disease</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">interferon-stimulated genes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>8</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37565734</ArticleId><ArticleId IdType="doi">10.1002/jmv.29030</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Kinobe R, Wiyatno A, Artika IM, Safari D. Insight into the Enterovirus A71: a review. Rev Med Virol. 2022;32(6):e2361.</Citation></Reference><Reference><Citation>Huang PN, Shih SR. Update on enterovirus 71 infection. Curr Opin Virol. 2014;5:98-104.</Citation></Reference><Reference><Citation>Yuan J, Shen L, Wu J, et al. Enterovirus A71 proteins: structure and function. Front Microbiol. 2018;9:286.</Citation></Reference><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129(3):304-309.</Citation></Reference><Reference><Citation>Fu X, Wan Z, Li Y, Hu Y, Jin X, Zhang C. National epidemiology and evolutionary history of four hand, foot and mouth disease-related enteroviruses in China from 2008 to 2016. Virol Sin. 2020;35(1):21-33.</Citation></Reference><Reference><Citation>Sadler AJ, Williams BRG. Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008;8(7):559-568.</Citation></Reference><Reference><Citation>Schoggins JW. Interferon-stimulated genes: what do they all do? Annu Rev Virol. 2019;6(1):567-584.</Citation></Reference><Reference><Citation>Suzuki Y, Chin WX, Han Q, et al. Characterization of RyDEN (C19orf66) as an interferon-stimulated cellular inhibitor against dengue virus replication. PLoS Pathog. 2016;12(1):e1005357.</Citation></Reference><Reference><Citation>Rodriguez W, Muller M. Shiftless, a critical piece of the innate immune response to viral infection. Viruses. 2022;14(6):1338.</Citation></Reference><Reference><Citation>Balinsky CA, Schmeisser H, Wells AI, et al. IRAV (FLJ11286), an interferon-stimulated gene with antiviral activity against dengue virus, interacts with MOV10. J Virol. 2017;91(5):e01606-e01616.</Citation></Reference><Reference><Citation>Wang X, Xuan Y, Han Y, et al. Regulation of HIV-1 Gag-Pol expression by shiftless, an inhibitor of programmed-1 ribosomal frameshifting. Cell. 2019;176(3):625-635.e14.</Citation></Reference><Reference><Citation>Rodriguez W, Srivastav K, Muller M. C19ORF66 broadly escapes virus-induced endonuclease cleavage and restricts Kaposi's sarcoma-associated herpesvirus. J Virol. 2019;93(12):e00373-e00319.</Citation></Reference><Reference><Citation>Wu Y, Yang X, Yao Z, et al. C19orf66 interrupts Zika virus replication by inducing lysosomal degradation of viral NS3. PLoS Negl Trop Dis. 2020;14(3):e0008083.</Citation></Reference><Reference><Citation>Kinast V, Plociennikowska A, Anggakusuma A, et al. C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle. J Hepatol. 2020;73(3):549-558.</Citation></Reference><Reference><Citation>Yu D, Zhao Y, Pan J, et al. C19orf66 inhibits Japanese encephalitis virus replication by targeting -1 PRF and the NS3 protein. Virol Sin. 2021;36(6):1443-1455.</Citation></Reference><Reference><Citation>Napthine S, Hill CH, Nugent HCM, Brierley I. Modulation of viral programmed ribosomal frameshifting and stop codon readthrough by the host restriction factor shiftless. Viruses. 2021;13(7):1230.</Citation></Reference><Reference><Citation>Hanners NW, Mar KB, Boys IN, et al. Shiftless inhibits flavivirus replication in vitro and is neuroprotective in a mouse model of Zika virus pathogenesis. Proc Natl Acad Sci USA. 2021;118(49):e2111266118.</Citation></Reference><Reference><Citation>Rodriguez W, Mehrmann T, Hatfield D, Muller M. Shiftless restricts viral gene expression and influences RNA granule formation during Kaposi's sarcoma-associated herpesvirus lytic replication. J Virol. 2022;96(22):e0146922.</Citation></Reference><Reference><Citation>Suzuki Y, Murakawa T. Restriction of flaviviruses by an interferon-stimulated gene SHFL/C19orf66. Int J Mol Sci. 2022;23(20):12619.</Citation></Reference><Reference><Citation>Wang H, Kong N, Jiao Y, et al. EGR1 suppresses porcine epidemic diarrhea virus replication by regulating IRAV to degrade viral nucleocapsid protein. J Virol. 2021;95(19):e0064521.</Citation></Reference><Reference><Citation>Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019;366(6467):818-822.</Citation></Reference><Reference><Citation>Dantuma NP, Masucci MG. The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies. Semin Cancer Biol. 2003;13(1):69-76.</Citation></Reference><Reference><Citation>Si X, McManus BM, Zhang J, et al. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway. J Virol. 2005;79(13):8014-8023.</Citation></Reference><Reference><Citation>Widjaja I, de Vries E, Tscherne DM, García-Sastre A, Rottier PJM, de Haan CAM. Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a postfusion step. J Virol. 2010;84(18):9625-9631.</Citation></Reference><Reference><Citation>Giraldo MI, Vargas-Cuartas O, Gallego-Gomez JC, et al. K48-linked polyubiquitination of dengue virus NS1 protein inhibits its interaction with the viral partner NS4B. Virus Res. 2018;246:1-11.</Citation></Reference><Reference><Citation>Giraldo MI, Xia H, Aguilera-Aguirre L, et al. Envelope protein ubiquitination drives entry and pathogenesis of Zika virus. Nature. 2020;585(7825):414-419.</Citation></Reference><Reference><Citation>Davis ME, Gack MU. Ubiquitination in the antiviral immune response. Virology. 2015;479-480:52-65.</Citation></Reference><Reference><Citation>Çetin G, Klafack S, Studencka-Turski M, Krüger E, Ebstein F. The ubiquitin-proteasome system in immune cells. Biomolecules. 2021;11(1):60.</Citation></Reference><Reference><Citation>Khong WX, Yan B, Yeo H, et al. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol. 2012;86(4):2121-2131.</Citation></Reference><Reference><Citation>Rasti M, Khanbabaei H, Teimoori A. An update on enterovirus 71 infection and interferon type I response. Rev Med Virol. 2019;29(1):e2016.</Citation></Reference><Reference><Citation>Han Y, Wang L, Cui J, et al. SIRT1 inhibits EV71 genome replication and RNA translation by interfering with the viral polymerase and 5′UTR RNA. J Cell Sci. 2016;129(24):4534-4547.</Citation></Reference><Reference><Citation>Xiang Q, Wan P, Yang G, et al. Beclin1 binds to Enterovirus 71 3D protein to promote the virus replication. Viruses. 2020;12(7):756.</Citation></Reference><Reference><Citation>Wu Y, Lou Z, Miao Y, et al. Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China. Protein Cell. 2010;1(5):491-500.</Citation></Reference><Reference><Citation>Fan W, Mar KB, Sari L, et al. TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity. Cell. 2021;184(13):3410-3425.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>